Is Okta a Good Stock to Buy?
Okta (NASDAQ:OKTA) is used by some of the largest firms…
Sell
1
CGTX Quote, Financials, Valuation and Earnings
Last price:
$0.35
Seasonality move
:
-11.05%
Day range:
$0.34 - $0.39
52-week range:
$0.34 - $2.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.17x
Volume:
983.6K
Avg. volume:
2.1M
1-year change:
-81.65%
Market cap:
$22M
Revenue:
--
EPS (TTM):
-$0.87
Earnings Data
Next earnings date for CGTX
May 07
2025
Most recent earnings per share
-$0.17
Missed by $0.02
(Mar 20/2025)
Consensus Estimate
-$0.15
(Mar 20/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CGTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.10 | -- |
| 05/07/2025 | Q1 | -- | -- | -- | -$0.12 | -- |
| 03/20/2025 | Q4 | -- | -- | -$0.17 | -$0.15 | -$0.02 |
| 11/13/2024 | Q3 | -- | -- | -$0.25 | -$0.21 | -$0.04 |
| 08/08/2024 | Q2 | -- | -- | -$0.18 | -$0.23 | $0.05 |
| 05/07/2024 | Q1 | -- | -- | -$0.27 | -$0.25 | -$0.03 |
| 03/26/2024 | Q4 | -- | -- | -$0.27 | -$0.33 | $0.06 |
| 11/02/2023 | Q3 | -- | -- | -$0.22 | -$0.29 | $0.07 |
| 08/08/2023 | Q2 | -- | -- | -$0.16 | -$0.21 | $0.05 |
| 05/04/2023 | Q1 | -- | -- | -$0.21 | -$0.18 | -$0.04 |
| 03/23/2023 | Q4 | -- | -- | -$0.20 | -$0.30 | $0.10 |
| 11/14/2022 | Q3 | -- | -- | -$0.29 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$0.25 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.17 | -- | -- |
| 03/30/2022 | Q4 | -- | -- | -$0.34 | -- | -- |
| 11/17/2021 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.14 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.04 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.14 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.13 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.17 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.12 | -- | -- |
Cognition Therapeutics Earnings Questions
-
How Much did Cognition Therapeutics Generate in Revenue Last Quarter?
Cognition Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Cognition Therapeutics Beat Earnings Last Quarter?
Cognition Therapeutics announced earnings per share of -$0.17 which represents a miss of analyst forecast a -$0.15 per share.
-
Is Cognition Therapeutics Profitable?
Cognition Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cognition Therapeutics EPS Next Year?
Cognition Therapeutics's earnings are forecast to decrease from -$0.86 per share to -$0.40 per share next year representing a decrease of -53.49%.
-
When is Cognition Therapeutics's Earnings Date?
Cognition Therapeutics's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Fidelity High Dividend ETF a Good Investment Now?
Fidelity’s High Dividend ETF (FDVV) is a fund that offers…
Is Kinder Morgan Dividend Yield Worth It?
Kinder Morgan (NYSE:KMI) is a major energy infrastructure company in…
Stock Ideas
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
31
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 32x
Alerts
Sell
45
RGC alert for Apr 5
Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.
Sell
25
GDXU alert for Apr 5
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.
Buy
76
SOXS alert for Apr 5
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.
